Rigel Pharmaceuticals (RIGL) Prepaid Assets (2010 - 2026)
Rigel Pharmaceuticals (RIGL) posted quarterly Prepaid Assets of $25.7 million for Q1 2026, up 303.8% year-over-year from $6.4 million in Q1 2025, and up 17.34% quarter-over-quarter from $21.9 million in Q4 2025.
Analysis
Rigel Pharmaceuticals (RIGL) Prepaid Assets (2010 - 2026) Analysis & Trends
Rigel Pharmaceuticals' Prepaid Assets history runs 17 years deep, the most recent figure standing at $25.7 million for Q1 2026.
- In Q1 2026, Prepaid Assets rose 303.8% year-over-year to $25.7 million; the TTM figure through Mar 2026 stood at $25.7 million (up 303.8% YoY), while the FY2025 annual figure was $21.9 million, up 115.86% from the prior year.
- Prepaid Assets for Q1 2026 stood at $25.7 million, up from $21.9 million in the prior quarter.
- The five-year high for Prepaid Assets was $25.7 million in Q1 2026, with the low at $3.0 million in Q3 2023.
- The 5-year median for Prepaid Assets is $7.9 million (2022), against an average of $9.2 million.
- The sharpest annual moves came in 2023 and 2026: Prepaid Assets tumbled 51.03% in 2023, then surged 303.8% in 2026.
- Rigel Pharmaceuticals' Prepaid Assets stood at $8.3 million in 2022, then fell by 24.19% to $6.3 million in 2023, then soared by 62.35% to $10.2 million in 2024, then surged by 115.86% to $21.9 million in 2025, then climbed by 17.34% to $25.7 million in 2026.
- Business Quant data shows RIGL's Prepaid Assets at $25.7 million in Q1 2026, $21.9 million in Q4 2025, and $5.9 million in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.31 Bn | 131.46 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.65 Bn | 77.66 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.46 Bn | 58.27 Bn | 1.37 Bn |
| 4 | Moderna | 57.94 Bn | 52.80 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.05 Bn | 44.05 Bn | - |
| 6 | BeOne Medicines | 39.96 Bn | 34.86 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.16 Bn | 31.85 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.44 Bn | 27.60 Bn | - |
| 9 | Insmed | 27.32 Bn | 26.16 Bn | 358.27 Mn |
| 10 | Rigel Pharmaceuticals | 902.02 Mn | 806.69 Mn | 70.18 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 19.79 Mn |
| Mar 31, 2026 | 25.75 Mn |
| Dec 31, 2025 | 21.94 Mn |
| Sep 30, 2025 | 18.56 Mn |
| Jun 30, 2025 | 16.68 Mn |
| Mar 31, 2025 | 23.26 Mn |
| Dec 31, 2024 | 10.17 Mn |
| Sep 30, 2024 | 9.99 Mn |
| Jun 30, 2024 | 8.66 Mn |
| Mar 31, 2024 | 8.85 Mn |
| Dec 31, 2023 | 6.26 Mn |
| Sep 30, 2023 | 3.02 Mn |
| Jun 30, 2023 | 4.97 Mn |
| Mar 31, 2023 | 7.87 Mn |
| Dec 31, 2022 | 8.26 Mn |
| Sep 30, 2022 | 6.16 Mn |
| Jun 30, 2022 | 7.94 Mn |
| Mar 31, 2022 | 9.42 Mn |
| Dec 31, 2021 | 7.41 Mn |
| Sep 30, 2021 | 5.93 Mn |